Annual Lynn Sage Breast Cancer Symposium

Lynn Sage Breast Cancer Symposium has been called the most valuable breast cancer meeting worldwide for the practicing clinician. For over 20 years, this multidisciplinary CME event has been bringing together leading national and international medical, surgical and radiation oncologists to present, debate and evaluate cutting-edge technology and approaches in the management of breast cancer. New options are occurring in all aspects of patient care including prevention, screening, and detection, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, novel biologic therapies as well as survivorship. This symposium focuses on the multidisciplinary cooperation that is required for the management of today’s breast cancer patient.

Advances in Breast Cancer Research

Make plans to join leading basic, translational, and clinical investigators at the tenth AACR Special Conference on Advances in Breast Cancer Research. This year’s program will once again address basic and translational breast cancer research not typically covered in other breast cancer conferences with a more clinical agenda. Topics will include novel model systems, inflammation and the microenvironment, genomics, heterogeneity, personalized risk and prevention, and future therapies and immuno-oncology.

Annual Lynn Sage Breast Cancer Symposium

Lynn Sage Breast Cancer Symposium has been called the most valuable breast cancer meeting worldwide for the practicing clinician. For over 20 years, this multidisciplinary CME event has been bringing together leading national and international medical, surgical and radiation oncologists to present, debate and evaluate cutting-edge technology and approaches in the management of breast cancer. New options are occurring in all aspects of patient care including prevention, screening, and detection, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, novel biologic therapies as well as survivorship. This symposium focuses on the multidisciplinary cooperation that is required for the management of today’s breast cancer patient.

12th European Breast Cancer Conference

The 12th edition of the European Breast Cancer Conference (EBCC-12) will provide a unique multidisciplinary setting for all professionals with a common interest in breast cancer to discuss, debate, inform and educate themselves about this evolving disease landscape.

This international conference is directed towards a broad audience including scientists, clinicians, patient representatives and health professionals of diverse profiles who tackle key issues facing patients throughout the continuum of the breast cancer journey.

Society for Immunotherapy of Cancer Annual Meeting (SITC 2019)

The Society for Immunotherapy of Cancer (SITC) Annual Meeting brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on cancer immunotherapy.

As the largest conference solely focused on cancer immunotherapy, the Annual Meeting provides international leaders from academia, regulatory and government agencies, as well as industry representatives with a multidisciplinary educational and interactive environment focused on improving outcomes for all cancer patients.

8th International Congress on Cancer Metastasis

The program follows the journey of cancer metastasis from detection at the molecular level to genomic identification to precision treatment and survival.

With more detailed understanding of the genomic and molecular characteristics of cancer, we are closer towards the practice of precision medicine with tailored approaches to individual patient or groups of patients. It is our plan to address these issues in detail with the goal to bring basic scientists, oncologists, surgeons and radiologists from around the world together to allow cross-fertilization of ideas resulting in the translation of basic science into clinical application and challenging basic scientists with clinical issues. We hope that with advancements in cancer biology, treatment and care, caner survivors may live longer and enjoy an improved quality of life than before.

Annual Lynn Sage Breast Cancer Symposium

Lynn Sage Breast Cancer Symposium has been called the most valuable breast cancer meeting worldwide for the practicing clinician. For over 20 years, this multidisciplinary CME event has been bringing together leading national and international medical, surgical and radiation oncologists to present, debate and evaluate cutting-edge technology and approaches in the management of breast cancer. New options are occurring in all aspects of patient care including prevention, screening, and detection, as well as in the primary treatment modalities of surgery, radiation therapy, endocrine therapy, cytotoxic chemotherapy, novel biologic therapies as well as survivorship. This symposium focuses on the multidisciplinary cooperation that is required for the management of today’s breast cancer patient.

Fifth International Cancer lmmunotherapy Conference

The Fifth International Cancer lmmunotherapy Conference will focus on “Translating Science into Survival,” and feature talks from more than 50 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy, including: regulating T cells and their response to cancer, tumor microenvironment, genetically engineered T cells, maintenance of immune balance, novel vaccine platforms and combinations, mutational analysis and predicting response to immunotherapy, convergence of technology and cancer immunotherapy, microbiome, and metabolism.

This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates.

Annual Personalized Cancer Vaccines Conference

Recent developments in personalized cancer vaccines are enabling the next generation of rational cancer immunotherapy. Cancer vaccines now may be combined with other immunotherapies, dendritic cells used for personalized immunotherapy, and neoantigens on the surface of cancer cells targeted, matching vaccine components to each patient. mRNA- and DNA-based vaccines present an additional opportunity for cancer therapeutics. Cambridge Healthtech Institute’s Annual Personalized Cancer Vaccines meeting will cover applications in several types of cancer and the progress in the understanding of the immune system that has significantly advanced the potential of cancer vaccines.

Up ↑